U.S. markets open in 2 hours 20 minutes

Anika Therapeutics, Inc. (ANIK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
22.48+0.51 (+2.32%)
At close: 04:00PM EST
22.72 +0.24 (+1.07%)
After hours: 05:27PM EST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 12/8/2023
Market Cap (intraday)
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (5 yr expected)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Trading Information

Stock Price History

Beta (5Y Monthly) 0.73
52-Week Change 3-26.63%
S&P500 52-Week Change 316.55%
52 Week High 332.33
52 Week Low 316.54
50-Day Moving Average 320.08
200-Day Moving Average 323.50

Share Statistics

Avg Vol (3 month) 3183.9k
Avg Vol (10 day) 3121.23k
Shares Outstanding 514.64M
Implied Shares Outstanding 614.64M
Float 811M
% Held by Insiders 12.72%
% Held by Institutions 189.41%
Shares Short (Nov 14, 2023) 4489.11k
Short Ratio (Nov 14, 2023) 44.6
Short % of Float (Nov 14, 2023) 44.76%
Short % of Shares Outstanding (Nov 14, 2023) 43.34%
Shares Short (prior month Oct 12, 2023) 4468.17k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Sep 29, 2023


Profit Margin -15.05%
Operating Margin (ttm)-18.51%

Management Effectiveness

Return on Assets (ttm)-5.05%
Return on Equity (ttm)-8.85%

Income Statement

Revenue (ttm)163.31M
Revenue Per Share (ttm)11.15
Quarterly Revenue Growth (yoy)3.00%
Gross Profit (ttm)96.78M
EBITDA -13.02M
Net Income Avi to Common (ttm)-24.57M
Diluted EPS (ttm)-1.68
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)70.65M
Total Cash Per Share (mrq)4.83
Total Debt (mrq)29.31M
Total Debt/Equity (mrq)10.84%
Current Ratio (mrq)5.59
Book Value Per Share (mrq)18.48

Cash Flow Statement

Operating Cash Flow (ttm)-4.95M
Levered Free Cash Flow (ttm)1.79M